| Effect of nalbuphine on the motility of the sphincter of Oddi in patients with suspected sphincter of Oddi dysfunction. | |
| | |
MedLine Citation:
|
PMID: 12612509 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Nalbuphine is an ideal supplementary analgesic drug for midazolam-induced conscious sedation during operative endoscopy because it has no cardiovascular effect and only a moderate depressive effect on respiration. However, no data are available as to whether nalbuphine is suitable as an analgesic drug during endoscopic sphincter of Oddi manometry. The aim of the present study was to investigate the effect of nalbuphine on the sphincter of Oddi motility in patients with a suspected sphincter of Oddi dysfunction. METHODS: Seventeen patients who were suspected clinically to have SOD after cholecystectomy were prospectively investigated. Five mg of midazolam was administered intravenously before the procedure to induce conscious sedation. After approximately 5 minutes of stationary sphincter of Oddi manometry recording (baseline), either 10 mg of nalbuphine or saline solution (placebo) was administered intravenously in random fashion and pressure was recorded for a further 5 minutes. Maximum sphincter of Oddi basal pressure and average phasic contraction amplitude and frequency were measured before and after the infusion of the drug or saline solution. RESULTS: Nalbuphine administration effectively enhanced the sedation obtained with midazolam without any adverse effect. When the sphincter of Oddi manometric periods before and after the administration of nalbuphine versus placebo were compared, there was a significantly increased basal sphincter of Oddi pressure only in the nalbuphine group: respectively, 49 (18) and 77 (29) mm Hg (p = 0.003) versus 51 (24) and 49 (23) mm Hg (p = 0.9). The phasic contraction amplitude did not change in response to nalbuphine, but the phasic contraction frequency increased significantly, from 5 (3) to 8 (4) per minute (p = 0.04). CONCLUSIONS: Nalbuphine has a stimulatory effect on sphincter of Oddi motility in patients with a suspected sphincter of Oddi dysfunction. Nalbuphine should not be used as premedication before endoscopic ERCP if sphincter of Oddi manometry is to be performed. |
| | |
Authors:
|
László Madácsy; Viktória Bertalan; Attila Szepes; János Lonovics |
Related Documents
:
|
3238549 - Manometric evaluation of esophageal motility in patients submitted to prophylactic vari... 7129339 - Fundic pressure rise lowers lower esophageal sphincter pressure in man. 9052509 - Effects of omeprazole on mechanisms of gastroesophageal reflux in childhood. 6696109 - Evidence for an opiate-mediated pyloric sphincter reflex. 11083449 - Motor function of the esophagus and the lower esophageal sphincter in children who unde... 3219549 - Physiological parameters influencing function in restorative proctocolectomy and ileo-p... 12558319 - Third model of the undulation pump total artificial heart. 20833959 - Local angiotensin ii aggravates cardiac remodeling in hypertension. 10694109 - Acute creatine loading increases fat-free mass, but does not affect blood pressure, pla... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Gastrointestinal endoscopy Volume: 57 ISSN: 0016-5107 ISO Abbreviation: Gastrointest. Endosc. Publication Date: 2003 Mar |
Date Detail:
|
Created Date: 2003-03-03 Completed Date: 2003-06-09 Revised Date: 2006-09-18 |
Medline Journal Info:
|
Nlm Unique ID: 0010505 Medline TA: Gastrointest Endosc Country: United States |
Other Details:
|
Languages: eng Pagination: 319-23 Citation Subset: IM |
Affiliation:
|
First Department of Internal Medicine, University of Szeged, Szeged, Hungary. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Analgesics, Opioid
/
diagnostic use,
pharmacology* Common Bile Duct Diseases / diagnosis*, physiopathology Conscious Sedation Female Gastrointestinal Motility / drug effects* Humans Male Manometry Middle Aged Nalbuphine / diagnostic use, pharmacology* Sphincter of Oddi / drug effects*, physiopathology Stimulation, Chemical |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics, Opioid; 20594-83-6/Nalbuphine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cost-effectiveness of screening a population with chronic gastroesophageal reflux.
Next Document: A prospective, randomized trial of endoscopic hemoclip placement and distilled water injection for t...